Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Expand chart
Data: Axios/Ipsos Poll; Note: Margin of error +/-3.2%; Chart: Kavya Beheraj/Axios

A majority of Americans — including suburban voters — support vaccine mandates for federal workers as well as private companies, according to the latest installment of the Axios/Ipsos Coronavirus Index.

Why it matters: The findings, on the heels of President Biden's mandates announcement last week, suggest that while his move was divisive, it may be politically safer than his opponents hope.

What they're saying: "From a political perspective, he especially reinforces himself with independents," said Cliff Young, president of Ipsos U.S. Public Affairs.

  • "The No. 1 issue for Biden has been COVID, and he’s been losing ground on it, especially among independents ... it should stanch the bleeding ... this is an initiative that could help bolster him there."
  • However, "he wins no points with Republicans. He wins a lot of points with Democrats, but they already support him."

The big picture: Respondents were asked two separate questions: Do you support the federal government requiring all federal employees to be vaccinated against COVID-19? And do you support a federal government rule that requires all business with 100 or more employees to make all staff be vaccinated or undergo regular COVID testing?

  • Their overall responses were virtually identical: 42% strongly supported both; 18% somewhat supported both; 13%–14% somewhat opposed both; and 25%–26% strongly opposed both.
  • In other words, respondents didn't draw major distinctions between mandates for public or private employees.

Between the lines: The high concentrations of strong support and strong opposition reinforce the depth of polarization.

By the numbers: About seven in 10 urban respondents supported the mandates or testing requirements, compared with nearly six in 10 suburban voters — and a little less than half of rural voters.

  • About two-thirds of respondents 65 and older, or under 30, support the mandates — compared with a little more than half of those in between.

Between the lines: Pollsters also asked this week's respondents which of the following options should be the federal government's current COVID vaccine policy priority.

  • 38% said redoubling efforts to get remaining unvaccinated Americans vaccinated. (That included nearly half of vaccinated respondents, but only one in 10 unvaccinated respondents.)
  • 28% would prioritize booster shots for every American who wants one.
  • 19% would prioritize making shots accessible to people in developing countries.

Methodology: This Axios/Ipsos Poll was conducted Sept. 10–13 by Ipsos' KnowledgePanel®. This poll is based on a nationally representative probability sample of 1,065 general population adults age 18 or older.

  • The margin of sampling error is ±3.2 percentage points at the 95% confidence level, for results based on the entire sample of adults.

Go deeper

Sep 22, 2021 - Health

FDA approves Pfizer boosters for high-risk individuals, people 65 and up

Photo: Paul Hennessy/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration on Wednesday approved Pfizer-BioNTech coronavirus booster shots for people at high risk of severe COVID-19 and people 65 years and older.

Driving the news: The approval comes just days after an FDA advisory panel recommended boosters for the two groups but overwhelmingly voted against the third shots for younger Americans.

13 hours ago - Health

CDC panel recommends Pfizer boosters for high-risk individuals, people 65 and up

Photo: Marco Bello/Anadolu Agency via Getty Images

A key panel at the Centers for Disease Control and Prevention on Thursday recommended the Pfizer-BioNTech coronavirus booster shots for people 65 years old and older, as well as those at high risk of severe COVID-19.

Why it matters: The approval is the near-final step in making the booster shots available to tens of millions of Americans, and comes a day after the FDA approved Pfizer boosters for the two groups. CDC director Rochelle Walensky is expected to announce her recommendation soon.

Updated 17 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Vaccines: FDA approves Pfizer boosters for high-risk individuals, people 65 and up — Team USA to mandate vaccine for Winter Olympic hopefuls — U.S. to buy 500 million more Pfizer doses to share with the world.
  2. Health: Some experts see signs of hope as cases fall — WHO: Nearly 1 in 4 Afghan COVID hospitals shut after Taliban takeover — D.C. goes further than area counties with vaccine mandates.
  3. Politics: Bolsonaro isolating after health minister tests positive at UN summit — United Airlines says 97% of U.S. employees fully vaccinated — Mormon Church to mandate masks in temples.
  4. Education: Asymptomatic Florida students exposed to COVID no longer have to quarantine — Education Department investigating Texas mask mandate ban — D.C. schools to require teachers, staff to receive vaccine without testing option.
  5. Variant tracker: Where different strains are spreading.